Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Arcus Biosciences' Tax Provisions history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2024.

• On a quarterly basis, Tax Provisions changed 0.0% year-over-year to $1.0 million in Q4 2024; TTM through Sep 2025 was $1.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $1.0 million, down 83.33% from the prior year.
• Tax Provisions steadied at $1.0 million in Q4 2024 per RCUS's latest filing, from $1.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $2.0 million in Q4 2021 and bottomed at $1.0 million in Q1 2022.
• The 4-year median for Tax Provisions is $1.0 million (2022), against an average of $1.4 million.
• Across the five-year window, Tax Provisions jumped 100.0% in 2023 and changed 0.0% in 2024, its largest moves.
• Year by year, Tax Provisions stood at $2.0 million in 2021, then sank by 50.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
• Per Business Quant, the three latest RCUS Tax Provisions figures stand at $1.0 million (Q4 2024), $1.0 million (Q4 2023), and $2.0 million (Q3 2023).